Innate Pharma (IPHA) Interest Coverage Ratio (2019 - 2025)
Innate Pharma's (IPHA) quarterly Interest Coverage Ratio came in at 16.76 in Q4 2025, up 24.66% YoY from 13.45 in Q4 2024, and up 84.78% on a QoQ basis from 9.07 in Q2 2025.
Innate Pharma (IPHA) Interest Coverage Ratio (2019 - 2025) Analysis & Trends
Innate Pharma (IPHA) has 7 years of Interest Coverage Ratio data on file, last reported at 16.76 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 24.66% year-over-year to 16.76 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 13.19 (up 30.48% YoY) and the FY2025 annual result came in at 17.31, down 33.41% from the prior year.
- Interest Coverage Ratio climbed to 16.76 in Q4 2025, from 9.07 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 3087.83 in Q4 2022 to a low of 0.41 in Q2 2023.
- A 5-year average of 394.67 and a median of 12.36 in 2021 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 25706.67% — and 2023, when it tumbled 99.83%.
- Tracing IPHA's Interest Coverage Ratio over 5 years: stood at 11.97 in 2021, then jumped by 25706.67% to 3087.83 in 2022, then plunged by 99.83% to 5.13 in 2023, then surged by 162.33% to 13.45 in 2024, then grew by 24.66% to 16.76 in 2025.
- The last three Interest Coverage Ratio figures came in at 16.76 (Q4 2025), 9.07 (Q2 2025), and 13.45 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Innate Pharma | 202.03 Mn | 202.03 Mn | - | 16.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.76 |
| Jun 30, 2025 | 9.07 |
| Dec 31, 2024 | 13.45 |
| Jun 30, 2024 | 12.75 |
| Dec 31, 2023 | 5.13 |
| Jun 30, 2023 | 0.41 |
| Dec 31, 2022 | 3,087.83 |
| Dec 31, 2021 | 11.97 |
| Dec 31, 2020 | 1.12 |
| Dec 31, 2019 | 5.17 |